{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:35:17Z","timestamp":1791174917828,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.exer.2008.04.002","type":"journal-article","created":{"date-parts":[[2008,4,13]],"date-time":"2008-04-13T12:15:44Z","timestamp":1208088944000},"page":"162-167","source":"Crossref","is-referenced-by-count":88,"title":["Hyaluronic acid coated poly-\u025b-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea"],"prefix":"10.1016","volume":"87","author":[{"given":"\u0130rem","family":"Yenice","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet C.","family":"Mocan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erhan","family":"Palaska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Bochot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erem","family":"Bilensoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130mran","family":"Vural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murat","family":"\u0130rke\u00e7","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Atilla H\u0131ncal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2008.04.002_bib1","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":"A randomized trial of topical cyclosporin 0.05% in topical steroid-resistant atopic keratoconjunctivitis","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2008.04.002_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1097\/00003226-200208000-00018","article-title":"Danger of systemic cyclosporine for corneal graft","volume":"21","author":"Algros","year":"2002","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2008.04.002_bib3","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0168-3659(02)00207-9","article-title":"Design of poly-epsilon-caprolactone nanospheres coated with bioadhesive hyaluronic acid for ocular delivery","volume":"83","author":"Barbault-Foucher","year":"2002","journal-title":"J. Control. Rel."},{"key":"10.1016\/j.exer.2008.04.002_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1007\/BF02154739","article-title":"The effect of topical cyclosporin A on rabbit cornea: a clinical and electron microscope study. Graefes Arch","volume":"224","author":"Behrens-Baumann","year":"1986","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2008.04.002_bib5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00003226-199007000-00002","article-title":"Update on topical cyclosporin A, background, immunology and pharmacology","volume":"9","author":"Belin","year":"1990","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2008.04.002_bib6","first-page":"1362","article-title":"Ocular penetration of cyclosporin A","volume":"31","author":"BenEzra","year":"1990","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2008.04.002_bib7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/bjo.74.6.350","article-title":"Ocular penetration of cyclosporin A. III: the human eye","volume":"74","author":"BenEzra","year":"1990","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2008.04.002_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1023\/A:1016015803611","article-title":"Polyester nanocapsules as new topical ocular delivery systems for cyclosporin A","volume":"13","author":"Calvo","year":"1996","journal-title":"Pharm. Res."},{"key":"10.1016\/j.exer.2008.04.002_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1442-9071.2004.00782.x","article-title":"Corneal epithelial cellular dysfunction from benzalkonium chloride (BKC) in vitro","volume":"32","author":"Cha","year":"2004","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.exer.2008.04.002_bib10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0378-5173(01)00760-8","article-title":"Chitosan nanoparticles: a new vehicle for the improvement of the delivery of drugs to the ocular surface. Application to cyclosporin A","volume":"224","author":"De Campos","year":"2001","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2008.04.002_bib11","first-page":"642","article-title":"Quaternary ammoniums and other preservatives\u2019 contribution in oxidative stress and apoptosis on chang conjunctival cells","volume":"42","author":"Debbasch","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2008.04.002_bib12","first-page":"2525","article-title":"Mitochondrial activity and glutathione injury in apoptosis induced by unpreserved and preserved \u03b2-blockers on chang conjunctival cells","volume":"42","author":"Debbasch","year":"2001","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2008.04.002_bib13","first-page":"3409","article-title":"Cytoprotective effects of hyaluronic acid and carbomer 934P in ocular surface epithelial cells","volume":"43","author":"Debbasch","year":"2002","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2008.04.002_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0378-5173(94)00389-M","article-title":"Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye","volume":"118","author":"Durrani","year":"1995","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2008.04.002_bib15","doi-asserted-by":"crossref","first-page":"472","DOI":"10.2165\/00003088-199324060-00004","article-title":"Cyclosporin clinical pharmacokinetics","volume":"24","author":"Fahr","year":"1993","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.exer.2008.04.002_bib16","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1016\/0378-5173(89)90281-0","article-title":"Nanocapsule formation by interfacial polymer deposition following solvent displacement","volume":"55","author":"Fessi","year":"1989","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2008.04.002_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/eye.2001.10","article-title":"Topical cyclosporin A in the management of vernal keratoconjunctivitis","volume":"15","author":"Gupta","year":"2001","journal-title":"Eye"},{"key":"10.1016\/j.exer.2008.04.002_bib18","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00915740","article-title":"Bioavailability of microsphere-entrapped cyclosporine A in the cornea and aqueous of rabbits","volume":"17","author":"Harper","year":"1993","journal-title":"Int. Ophthalmol."},{"key":"10.1016\/j.exer.2008.04.002_bib19","first-page":"3150","article-title":"The effect on the cornea of alpha cyclodextrin vehicle for cyclosporin eye drops","volume":"21","author":"Kanai","year":"1989","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.exer.2008.04.002_bib20","first-page":"119","article-title":"Penetration of cyclosporin A into the rabbit cornea and aqueous humor after topical drop and collagen shield administration","volume":"20","author":"Kanpolat","year":"1994","journal-title":"CLAO J"},{"issue":"Suppl. 2","key":"10.1016\/j.exer.2008.04.002_bib21","first-page":"650","article-title":"Intraocular penetration of topically applied cyclosporine","volume":"20","author":"Kaswan","year":"1988","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.exer.2008.04.002_bib22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1023\/A:1013671819604","article-title":"Cyclosporine A formulation affects its ocular distribution in rabbits","volume":"19","author":"Kuwano","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.exer.2008.04.002_bib23","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0939-6411(03)00138-3","article-title":"Cyclosporine A delivery to the eye: a pharmaceutical challenge","volume":"56","author":"Lallemand","year":"2003","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.exer.2008.04.002_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ijpharm.2004.12.015","article-title":"A novel water soluble cyclosporine A prodrug: ocular tolerance and in vivo kinetics","volume":"295","author":"Lallemand","year":"2005","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.exer.2008.04.002_bib25","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0039-6257(86)90035-4","article-title":"Cyclosporine: immunology, pharmacology and therapeutic uses","volume":"31","author":"Nussenblatt","year":"1986","journal-title":"Surv. Ophthalmol."},{"key":"10.1016\/j.exer.2008.04.002_bib26","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1023\/A:1016268922035","article-title":"Compartmental model for the ocular pharmacokinetics of cyclosporine in rabbits","volume":"12","author":"Oh","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.exer.2008.04.002_bib27","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/hlca.19760590509","article-title":"Crystal and molecular structure of an iodo derivative of the cyclic undecapeptide cyclosporin A","volume":"59","author":"Petcher","year":"1976","journal-title":"Helv. Chim. Acta"},{"key":"10.1016\/j.exer.2008.04.002_bib28","first-page":"527","article-title":"Collyre \u00e0 la cyclosporine a: fabrication, toxicit\u00e9, pharmacocin\u00e9tique et indications en l'an 2000","volume":"24","author":"Robert","year":"2001","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.exer.2008.04.002_bib29","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1136\/bjo.86.9.988","article-title":"Systemic cyclosporin A in high failure risk, repeated corneal transplantation","volume":"86","author":"Rumelt","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.exer.2008.04.002_bib30","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000310237","article-title":"Topical application of ciclosporin ophtalmic solution containing alpha-cyclodextrin in experimental uveitis","volume":"203","author":"Sasamoto","year":"1991","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.exer.2008.04.002_bib31","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1089\/jop.2000.16.439","article-title":"Comparison of tear sampling techniques for pharmacokinetic analysis: ofloxocin concentrations in rabbit tears after sampling with schirmer tear strips, capillary tubes, or surgical sponges","volume":"16","author":"Small","year":"2000","journal-title":"J. Ocul. Pharm. Ther."},{"key":"10.1016\/j.exer.2008.04.002_bib32","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2165\/00003088-200544030-00003","article-title":"Ocular pharmacokinetics and safety of ciclosporin, a novel topical treatment for dry eye","volume":"44","author":"Tang-Liu","year":"2005","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.exer.2008.04.002_bib33","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00007691-200404000-00023","article-title":"Therapeutic drug monitoring of immunosuppressant drugs by high performance liquid chromatography-mass spectrometry","volume":"26","author":"Taylor","year":"2004","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.exer.2008.04.002_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/108076802317233243","article-title":"Distribution of cyclosporin A in the cornea after topical and oral administration","volume":"18","author":"Theng","year":"2002","journal-title":"J. Ocul. Pharm. Ther."},{"key":"10.1016\/j.exer.2008.04.002_bib35","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/00003226-200107000-00013","article-title":"Effects of three penetration enhancers on transcorneal permeation of cyclosporine","volume":"20","author":"Van der Bijl","year":"2001","journal-title":"Cornea"},{"key":"10.1016\/j.exer.2008.04.002_bib36","first-page":"150","article-title":"Ocular distribution of cyclosporin A (sandimmun\u2122) following systemic and topical administration to rabbits","volume":"3","author":"Vernillet","year":"1991","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.exer.2008.04.002_bib37","first-page":"519","article-title":"Pharmacokinetics of topical cyclosporin A in the rabbit eye","volume":"27","author":"Wiederholt","year":"1986","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2008.04.002_bib38","doi-asserted-by":"crossref","first-page":"3983","DOI":"10.1167\/iovs.05-1373","article-title":"Cyclosporine-loaded microspheres for treatment of uveitis: in vitro characterization and in vivo pharmacokinetic study","volume":"47","author":"Yuan","year":"2006","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2008.04.002_bib39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0378-4347(00)00608-3","article-title":"Optimized analytical metod for cyclosporin A by high-performance liquid chromatography\u2013electrospray ionization mass spectrometry","volume":"754","author":"Zhou","year":"2001","journal-title":"J. Chromatogr. B."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483508001085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483508001085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,30]],"date-time":"2018-12-30T05:20:20Z","timestamp":1546147220000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483508001085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["S0014483508001085"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2008.04.002","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}